Health: pharmaceuticals; administration of epinephrine; modify. Amends secs. 17744a & 17744d of 1978 PA 368 (MCL 333.17744a & 333.17744d). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5051'25, HB 5052'25, HB 5053'25

Added specific definitions for 'authorized entity' to include school boards, businesses with allergens (like camps and sports arenas), and law enforcement/firefighter entities, and defined 'epinephrine delivery system' to include auto-injectors, inhalers, and nasal sprays.

Expanded eligibility to allow any trained employee or agent of an authorized entity to provide or administer epinephrine to an individual experiencing anaphylaxis, even if that individual has no prior allergy diagnosis or prescription.

Established mandatory training requirements for individuals administering epinephrine, requiring initial and biennial training from nationally recognized organizations covering symptom recognition, storage, and emergency procedures.

Added a requirement for authorized entities to designate a specific employee or agent responsible for the storage, maintenance, and oversight of the epinephrine supply.

Added a reporting requirement for authorized entities to submit incident reports to the Department of Health and Human Services regarding the administration of epinephrine.

Granted comprehensive immunity from civil liability (for negligence) and criminal prosecution to authorized entities, employees, prescribers, and training organizations when acting in accordance with the new rules.

Added a provision stating that the administration of epinephrine under this section is not considered the practice of medicine.